Kind MD vs. Found: Which Weight Loss Program Fits You Best?

Overview: two different approaches to medical weight loss

Medical weight loss has changed significantly in the last three years. GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have produced results that outperform anything previously available in non-surgical medicine. Clinical trials show average weight loss between 15% and 22.5% of body weight, and that evidence has driven a wave of telehealth programs offering access to these treatments.

Kind MD and Found both sit within this space, but they are built around meaningfully different philosophies. Understanding that difference matters before you commit to a program, because the right fit depends on what kind of support you want, how you think about medication, and what you are willing to pay for.

This comparison is written to be straightforward and fair. We will lay out what each program does, where it stands out, and where it has limitations so you can make an informed decision.

At-a-glance comparison

Here is how Kind MD and Found compare on the factors that matter most to most patients.

Medication approach: GLP-1 only vs. multi-drug

This is the most fundamental difference between the two programs, and it shapes everything else.

Kind MD: GLP-1 first and only

Kind MD is built around a single class of medication: GLP-1 receptor agonists. Specifically, compounded semaglutide and tirzepatide. These are the same active ingredients used in brand-name medications like Ozempic, Wegovy, Mounjaro, and Zepbound, sourced from FDA-registered 503B outsourcing facilities.

The rationale is straightforward. GLP-1 medications are the most clinically effective pharmacological weight loss tools available. The STEP trials published in the New England Journal of Medicine showed semaglutide producing average weight loss of 14.9% of body weight over 68 weeks. SURMOUNT-1 showed tirzepatide reaching up to 22.5% at the highest dose. No other approved medication comes close to those numbers.

By focusing exclusively on GLP-1, Kind MD keeps the program simple: one medication class, transparent pricing, no bundled services that add cost without adding clinical value for everyone.

Found: metabolic profiling across multiple medications

Found takes a different approach. Rather than starting from GLP-1 as the default, Found uses a metabolic assessment to determine which medication or combination of medications may work best for each patient's profile. This can include GLP-1s, but also off-label medications with established weight loss evidence: bupropion (normally an antidepressant), metformin (a diabetes drug), topiramate (an anticonvulsant), and naltrexone.

The logic is that obesity has multiple underlying drivers, and some patients may respond better to a different mechanism. Metformin, for example, improves insulin sensitivity and has decades of safety data. Bupropion affects dopamine pathways that influence appetite and food reward differently than GLP-1. Found's model is that a provider assessing your full metabolic picture may prescribe something other than a GLP-1, or a combination, depending on what your history and labs indicate.

The tradeoff is complexity. Found's multi-drug approach requires more intake information, more ongoing provider assessment, and more variables in the program. For patients who have already tried GLP-1 and want to explore alternatives, or who want a provider to evaluate all options from the start, that complexity is valuable. For patients who have researched their options and want GLP-1 access without the additional layer, it may feel like more than they need.

Pricing structure

Pricing in this space changes frequently, and specific numbers can shift as compounding pharmacy costs, supply, and regulations evolve. What does not change is the structural difference between how the two programs charge.

Kind MD pricing

Kind MD prices medication directly. You pay for what you receive: the medication, the provider consultation, and shipping. There is no separate monthly membership fee layered on top of the medication cost. This makes it easier to understand what you are paying for and to compare the actual cost of the medication against other sources.

Found pricing

Found charges a monthly membership fee that covers access to the platform, coaching, and provider oversight, in addition to the cost of medication. For patients who use the coaching and tracking features actively, this bundled model can represent good value. For patients who primarily want medication access and do not engage with the coaching side, the membership fee adds cost without corresponding benefit.

The practical question is whether you will use the platform Found is charging you for. If you want and will use coaching, app-based tracking, and a structured behavior change program, the bundled model makes sense. If you are looking for the most direct and cost-efficient path to GLP-1 medication, a membership fee on top of medication cost increases your monthly outlay without adding clinical value you will use.

Coaching and support

Found: high-touch coaching model

Found's platform is built around behavioral support alongside medication. Patients have access to health coaches via the app who can provide guidance on nutrition, movement, sleep, and habit formation. The program is designed around the idea that medication is most effective when combined with behavioral change, and Found's infrastructure is built to deliver both in one place.

For patients who want accountability, personalized guidance, or who have struggled with behavior change on their own in the past, this structure can be genuinely useful. Coaching is not a small thing. Access to a knowledgeable person who follows your progress and can offer real-time guidance has meaningful clinical value for many patients.

Kind MD: provider oversight without bundled coaching

Kind MD does not bundle coaching into the program. Patients have access to licensed providers for clinical oversight of their medication, but the program is not designed to deliver a comprehensive behavioral change curriculum alongside it.

This is a deliberate choice, not an oversight. Many patients who come to Kind MD have already done the research on GLP-1 medications, understand how the treatment works, and want straightforward access without paying for coaching they will not use. The GLP-1 medications themselves are the primary driver of outcome. The appetite suppression and metabolic effects of semaglutide and tirzepatide create the physiological conditions for weight loss. Extensive coaching infrastructure is not required for the medication to work.

Patients who want coaching alongside their medication can seek that independently. Registered dietitians, certified health coaches, and behavioral health providers are available separately and may be covered by insurance in ways that a bundled telehealth platform fee is not.

Technology and app

Found: integrated app platform

Found's app is central to the experience. It provides meal tracking, weight logging, habit tracking, coach messaging, and progress visualization. For patients who want a single interface where they manage their weight loss program, the app creates that. The design philosophy is that consolidating everything into one place reduces friction and increases engagement with healthy behaviors.

The app also gives Found's provider and coaching teams visibility into patient activity between appointments, which can make clinical adjustments more data-driven.

Kind MD: no dedicated app

Kind MD does not have a dedicated patient app. Communication with providers happens through the telehealth portal, and ongoing management is handled through standard patient outreach rather than a persistent app experience.

For patients who already track their health through a preferred tool (Apple Health, MyFitnessPal, or similar) or who do not want another app in their routine, this is not a limitation. For patients who find app-based accountability genuinely helpful for adherence, Found's platform offers something Kind MD does not.

Ordering process

Both programs follow a similar basic structure: complete an intake form, have a provider review your information, receive a prescription if appropriate, and have medication shipped to your home from a compounding pharmacy.

Kind MD is designed to make this process as direct as possible. The intake is focused, the provider review is efficient, and medication ships via expedited delivery. The experience is built around getting qualified patients their medication quickly without unnecessary steps in between.

Found's intake is more comprehensive given the broader medication evaluation it performs. The metabolic assessment requires more information about your history, any previous weight loss attempts, and your metabolic health markers. This is appropriate given that Found may prescribe from a wider range of options, but it means the process involves more steps before a prescription decision is made.

When to choose each program

Neither program is universally better. The right choice depends on what you are looking for. Here is a clear breakdown.

The clearest signal is this: if you have done your research on GLP-1 medications, understand what semaglutide or tirzepatide does, and want direct access without paying for infrastructure you will not use, Kind MD is purpose-built for that. If you want a platform to assess all your options, prescribe accordingly, and support your behavioral change through coaching and tracking, Found offers that more comprehensively.

Both programs require a legitimate clinical evaluation. Neither will prescribe GLP-1 medications to patients who do not meet clinical criteria (typically a BMI of 27 or higher with at least one weight-related comorbidity, or a BMI of 30 or higher). This is appropriate: these are prescription medications with real physiological effects, and provider oversight matters.